Significant Accounting Policies and Transactions (Details) - USD ($)		3 Months Ended			9 Months Ended
	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Jun. 30, 2024	May 31, 2024	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares authorized for grant								1,500,000
Number of options granted in period	297,974
Weighted average exercise price (in dollars per share)	$ 8.39
Inventory write-down				$ 30,100,000
Decrease in deferred tax asset valuation allowance			$ 123,200,000			$ 123,200,000
Deferred tax assets, net			0			0
Percentage of tax benefit paid to equity owner					85.00%
Obligations under tax receivable agreement	$ 0	$ 0	9,562,000		$ 0	9,562,000	$ 8,960,000		$ 8,960,000	$ 9,562,000	$ 109,187,000
Liability reduction		$ 0	$ 0		$ 0	$ 99,620,000
Restricted Stock Units (RSUs)
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of instruments granted in period (in shares)	481,510
Weighted average grant date fair value (in dollars per share)	$ 8.39